Industry Reports & Infographics

Find objective supply chain related reports, infographics and up-to-date pharma logistics information. 

223 whitepaper results
of 22

This 2017 report provides a snapshot of the industry’s status as it stands today and gives valuable insights on: Packaging and Labelling Regulatory Compliance, Artwork Management, New Technologies Trends, Patient Compliance and Tamper Evident Packaging Features. Learn more

Tags:

The global pharma market faces unprecedented complexities and pressures regarding the packaging and labelling of medicinal products. Ahead of the 2017 Packaging and Labelling Summit, this guide examines the changes required for pharmaceutical packaging to meet the requirements of EU Falsified Medicines Directive (FMD) and the crucial questions to ask in order to achieve compliance. Learn more

Tags:

The anti-tampering market is littered with challenges to address: meeting EU FMD requirements, satisfying country specific requirements, preserving patient usability and not to mention outwitting resourceful counterfeiters. Ahead of the packaging and labelling summit in June Pharma IQ explores the world of tamper evidence in pharma packaging Learn more

Tags:

Pharma IQ examines the opportunities available when maximizing the ROI of serialization and traceability systems beyond compliance. Learn more

Ahead of the traceability in operation forum 2017 Pharma IQ conducted some market research to pinpoint the concerns and priorities of those in the more mature phases of serialisation. Commentary supplied by Pasi Kemppainen, Executive Consultant, Pharma Serialization and Traceability. Learn more

Many will argue that the accountability of ensuring product safety and integrity lies with the manufacturer from production to the end point of the supply chain. After all, it is their name on the label. But if that is the case, then where does the responsibility lie once a product changes hands? Learn more

Tags:

A selection of experts have highlighted one key hurdle the market should brace for: data management with the EU UDI regime. Due to this area being expected to differ from the FDA’s GUDID process quite sharply in some places. With the MDR due to come into effect in a few years time, Pharma IQ gains insight on the forecasted data complexities attached to the EU’s UDI gameplan. Learn more

Tags:

Pharma Logistics IQ surveyed its network to pinpoint trends within Canada’s clinical and commercial temperature controlled supply chains. Learn more

Tags:

Lately, the need for heightened awareness and use of stability budgets within cold chain has been an industry focus. In a recent article Dr. Bishara and Dr. Erik J. van Asselt explained that a stability budget: “Refers to the quality of a product to resist, under specified conditions, irreversible change in its identity, strength, quality, and purity at various temperatures above and below the labelled claim storage temperature. Learn more

Tags:

Read Prisym's whitepaper “Mind Your Language! Requirements for Local Language Labeling in Clinical Trials” to find out about the critical elements involved in printing labels, booklets and IFUs and how to effectively use a software solution to manage the whole process. Learn more

Tags:
223 whitepaper results
of 22